Enabling Rapid Target Selection, Discovery & Rational Design of Degrading & Non-Degrading Molecular Glue to Develop Potent, Selective & Safer Cures for Cancer & Beyond
Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic.Â
Attendees will explore cutting-edge topics including target selection principles, rational design frameworks, sensitive assay technologies, lead optimization, and AI/ML approaches for rapid and reliable glue discovery. Delve into emerging frontiers in non-degrading molecular glues and approaches outside oncology to unlock new therapeutic modalities, expand glues to novel indications, and stay ahead of the curve in the glues space. 
If you’re looking to lead the way in the molecular glue space, connect with the brightest minds, and gain practical insights to drive programs forward – this is your chance to solve the field’s unique challenges and shape the next wave of innovative therapies.Â
This meeting serves as a catalyst for innovation bridging basic discovery and translation. Exploring new rational design frameworks and sensitive detection methods will advance our ability to systematically uncover and exploit molecular glue mechanisms
Mikolaj Slabicki, Principal Investigator, Massachusetts General Hospital
This meeting offers an opportunity to hear about a wide variety of strategies being employed to identify molecular glues and to connect with individuals who are bringing a high level of innovative problem solving to these challenges
Patrick Arsenault, Senior Director, Lead Discovery, Triana Biomedicines
As a scientist and entrepreneur, I see tremendous value in participating in the 4th Molecular Glue Drug Development meeting. It brings together leaders across industry and academia to share insights, challenges, and progress in a rapidly evolving field
Anita Bellail, Chief Executive Officer, HB Therapeutics
Explore the Full Event Guide
- 20+ Leading Molecular Glue Experts Presenting
- 3 Days of Data-Driven Glues Content
- Exclusive Networking & Partnership Opportunities
- 2 Interactive & Deep-Diving Workshops
- The Definitive Meeting for Molecular Glue Drug Discovery & Development
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest trends in molecular glue development and gain exclusive insights during our packed agenda, interactive roundtables and deep dive workshops.
Partner With Us
Position yourself as a leading solution provider within the molecular glue space to ensure your brand is at the heart of biopharma deals. Â
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees developing molecular glues, and make critical connections during our dedicated networking sessions.